These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 35418820)
1. Aicardi-Goutières Syndrome due to a Oleksy B; Mierzewska H; Tryfon J; Wypchło M; Wasilewska K; Zalewska-Miszkurka Z; Płoski R; Rydzanicz M; Szczepanik E Mol Syndromol; 2022 Feb; 13(2):132-138. PubMed ID: 35418820 [TBL] [Abstract][Full Text] [Related]
2. SAMHD1 compound heterozygous rare variants associated with moyamoya and mitral valve disease in the absence of other features of Aicardi-Goutières syndrome. Karla AR; Pinard A; Boerio ML; Hemelsoet D; Tavernier SJ; De Pauw M; Vereecke E; Fraser S; Bamshad MJ; Guo D; Callewaert B; Milewicz DM Am J Med Genet A; 2024 Apr; 194(4):e63486. PubMed ID: 38041217 [TBL] [Abstract][Full Text] [Related]
3. Aicardi-Goutières syndrome: A monogenic type I interferonopathy. Liu A; Ying S Scand J Immunol; 2023 Oct; 98(4):e13314. PubMed ID: 37515439 [TBL] [Abstract][Full Text] [Related]
4. Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond. Livingston JH; Crow YJ Neuropediatrics; 2016 Dec; 47(6):355-360. PubMed ID: 27643693 [TBL] [Abstract][Full Text] [Related]
5. Molecular Genetics and Interferon Signature in the Italian Aicardi Goutières Syndrome Cohort: Report of 12 New Cases and Literature Review. Garau J; Cavallera V; Valente M; Tonduti D; Sproviero D; Zucca S; Battaglia D; Battini R; Bertini E; Cappanera S; Chiapparini L; Crasà C; Crichiutti G; Dalla Giustina E; D'Arrigo S; De Giorgis V; De Simone M; Galli J; La Piana R; Messana T; Moroni I; Nardocci N; Panteghini C; Parazzini C; Pichiecchio A; Pini A; Ricci F; Saletti V; Salvatici E; Santorelli FM; Sartori S; Tinelli F; Uggetti C; Veneselli E; Zorzi G; Garavaglia B; Fazzi E; Orcesi S; Cereda C J Clin Med; 2019 May; 8(5):. PubMed ID: 31130681 [TBL] [Abstract][Full Text] [Related]
6. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Rice GI; Forte GM; Szynkiewicz M; Chase DS; Aeby A; Abdel-Hamid MS; Ackroyd S; Allcock R; Bailey KM; Balottin U; Barnerias C; Bernard G; Bodemer C; Botella MP; Cereda C; Chandler KE; Dabydeen L; Dale RC; De Laet C; De Goede CG; Del Toro M; Effat L; Enamorado NN; Fazzi E; Gener B; Haldre M; Lin JP; Livingston JH; Lourenco CM; Marques W; Oades P; Peterson P; Rasmussen M; Roubertie A; Schmidt JL; Shalev SA; Simon R; Spiegel R; Swoboda KJ; Temtamy SA; Vassallo G; Vilain CN; Vogt J; Wermenbol V; Whitehouse WP; Soler D; Olivieri I; Orcesi S; Aglan MS; Zaki MS; Abdel-Salam GM; Vanderver A; Kisand K; Rozenberg F; Lebon P; Crow YJ Lancet Neurol; 2013 Dec; 12(12):1159-69. PubMed ID: 24183309 [TBL] [Abstract][Full Text] [Related]
7. Systemic complications of Aicardi Goutières syndrome using real-world data. Peixoto de Barcelos I; Jan AK; Modesti N; Woidill S; Gavazzi F; Isaacs D; D'Aiello R; Sevagamoorthy A; Charlton L; Pizzino A; Schmidt J; van Haren K; Keller S; Eichler F; Emrick LT; Fraser JL; Shults J; Vanderver A; Adang LA Mol Genet Metab; 2024; 143(1-2):108578. PubMed ID: 39332260 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic and Molecular Spectrum of Aicardi-Goutières Syndrome: A Study of 24 Patients. Al Mutairi F; Alfadhel M; Nashabat M; El-Hattab AW; Ben-Omran T; Hertecant J; Eyaid W; Ali R; Alasmari A; Kara M; Al-Twaijri W; Filimban R; Alshenqiti A; Al-Owain M; Faqeih E; Alkuraya FS Pediatr Neurol; 2018 Jan; 78():35-40. PubMed ID: 29239743 [TBL] [Abstract][Full Text] [Related]
9. PNPT1 mutations may cause Aicardi-Goutières-Syndrome. Bamborschke D; Kreutzer M; Koy A; Koerber F; Lucas N; Huenseler C; Herkenrath P; Lee-Kirsch MA; Cirak S Brain Dev; 2021 Feb; 43(2):320-324. PubMed ID: 33158637 [TBL] [Abstract][Full Text] [Related]
10. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Crow YJ; Chase DS; Lowenstein Schmidt J; Szynkiewicz M; Forte GM; Gornall HL; Oojageer A; Anderson B; Pizzino A; Helman G; Abdel-Hamid MS; Abdel-Salam GM; Ackroyd S; Aeby A; Agosta G; Albin C; Allon-Shalev S; Arellano M; Ariaudo G; Aswani V; Babul-Hirji R; Baildam EM; Bahi-Buisson N; Bailey KM; Barnerias C; Barth M; Battini R; Beresford MW; Bernard G; Bianchi M; Billette de Villemeur T; Blair EM; Bloom M; Burlina AB; Carpanelli ML; Carvalho DR; Castro-Gago M; Cavallini A; Cereda C; Chandler KE; Chitayat DA; Collins AE; Sierra Corcoles C; Cordeiro NJ; Crichiutti G; Dabydeen L; Dale RC; D'Arrigo S; De Goede CG; De Laet C; De Waele LM; Denzler I; Desguerre I; Devriendt K; Di Rocco M; Fahey MC; Fazzi E; Ferrie CD; Figueiredo A; Gener B; Goizet C; Gowrinathan NR; Gowrishankar K; Hanrahan D; Isidor B; Kara B; Khan N; King MD; Kirk EP; Kumar R; Lagae L; Landrieu P; Lauffer H; Laugel V; La Piana R; Lim MJ; Lin JP; Linnankivi T; Mackay MT; Marom DR; Marques Lourenço C; McKee SA; Moroni I; Morton JE; Moutard ML; Murray K; Nabbout R; Nampoothiri S; Nunez-Enamorado N; Oades PJ; Olivieri I; Ostergaard JR; Pérez-Dueñas B; Prendiville JS; Ramesh V; Rasmussen M; Régal L; Ricci F; Rio M; Rodriguez D; Roubertie A; Salvatici E; Segers KA; Sinha GP; Soler D; Spiegel R; Stödberg TI; Straussberg R; Swoboda KJ; Suri M; Tacke U; Tan TY; te Water Naude J; Wee Teik K; Thomas MM; Till M; Tonduti D; Valente EM; Van Coster RN; van der Knaap MS; Vassallo G; Vijzelaar R; Vogt J; Wallace GB; Wassmer E; Webb HJ; Whitehouse WP; Whitney RN; Zaki MS; Zuberi SM; Livingston JH; Rozenberg F; Lebon P; Vanderver A; Orcesi S; Rice GI Am J Med Genet A; 2015 Feb; 167A(2):296-312. PubMed ID: 25604658 [TBL] [Abstract][Full Text] [Related]
11. Recurrent Encephalopathy with Spinal Cord Involvement: An Atypical Manifestation of Aicardi-Goutières Syndrome. Samanta D; Ramakrishnaiah R Ann Indian Acad Neurol; 2019; 22(1):111-115. PubMed ID: 30692772 [TBL] [Abstract][Full Text] [Related]
12. Developmental Outcomes of Aicardi Goutières Syndrome. Adang L; Gavazzi F; De Simone M; Fazzi E; Galli J; Koh J; Kramer-Golinkoff J; De Giorgis V; Orcesi S; Peer K; Ulrick N; Woidill S; Shults J; Vanderver A J Child Neurol; 2020 Jan; 35(1):7-16. PubMed ID: 31559893 [TBL] [Abstract][Full Text] [Related]
13. Systemic inflammation and chronic kidney disease in a patient due to the RNASEH2B defect. He T; Xia Y; Yang J Pediatr Rheumatol Online J; 2021 Jan; 19(1):9. PubMed ID: 33482855 [TBL] [Abstract][Full Text] [Related]
14. Generation of three induced pluripotent cell lines (iPSCs) from an Aicardi-Goutières syndrome (AGS) patient harboring a deletion in the genomic locus of the sterile alpha motif and HD domain containing protein 1 (SAMHD1). Fuchs NV; Schieck M; Neuenkirch M; Tondera C; Schmitz H; Wendeburg L; Steinemann D; Elpers C; Rutsch F; König R Stem Cell Res; 2020 Mar; 43():101697. PubMed ID: 32062129 [TBL] [Abstract][Full Text] [Related]
15. MDA5-Associated Neuroinflammation and the Singleton-Merten Syndrome: Two Faces of the Same Type I Interferonopathy Spectrum. Buers I; Rice GI; Crow YJ; Rutsch F J Interferon Cytokine Res; 2017 May; 37(5):214-219. PubMed ID: 28475458 [TBL] [Abstract][Full Text] [Related]